← Back to Clinical Trials
Recruiting NCT05943756

NCT05943756 Evaluation of Well-being Interventions in Adults With TBI

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05943756
Status Recruiting
Phase
Sponsor Kessler Foundation
Condition TBI (Traumatic Brain Injury)
Study Type INTERVENTIONAL
Enrollment 94 participants
Start Date 2023-09-25
Primary Completion 2026-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Signature StrengthsTBI Education Course

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 94 participants in total. It began in 2023-09-25 with a primary completion date of 2026-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this research is to evaluate the potential benefits of two Intervention programs in adults with TBI to improve well-being and other outcomes that are maintained over time.

Eligibility Criteria

Inclusion Criteria: * At least 18 years of age * Have a diagnosis with moderate to severe TBI * At least one year post injury * Able to speak and read English fluently Exclusion Criteria: * Have a history of multiple sclerosis, stroke, seizures or another nervous system injuries disease in the past (like brain tumor or epilepsy) * Have a significant psychiatric illness (like, schizophrenia or psychosis) * Currently taking steroids and/or benzodiazepines as determined by study staff review of medications * Significant alcohol or drug abuse history (requiring inpatient treatment) * History of stroke, schizoaffective disorder, bipolar disorder, personality disorder or severe depression determined by extensive screening by a trained staff member * Previous participation in a Signature Strengths program

Contact & Investigator

Central Contact

Helen Genova, Ph. D.

✉ hgenova@kesslerfoundation.org

📞 973-324-8390

Principal Investigator

Helen Genova, Ph. D.

PRINCIPAL INVESTIGATOR

Kessler Foundation

Frequently Asked Questions

Who can join the NCT05943756 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying TBI (Traumatic Brain Injury). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05943756 currently recruiting?

Yes, NCT05943756 is actively recruiting participants. Contact the research team at hgenova@kesslerfoundation.org for enrollment information.

Where is the NCT05943756 trial being conducted?

This trial is being conducted at East Hanover, United States.

Who is sponsoring the NCT05943756 clinical trial?

NCT05943756 is sponsored by Kessler Foundation. The principal investigator is Helen Genova, Ph. D. at Kessler Foundation. The trial plans to enroll 94 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology